MXPA04009338A - Formulaciones de un anhidrato en suspension con hfa. - Google Patents

Formulaciones de un anhidrato en suspension con hfa.

Info

Publication number
MXPA04009338A
MXPA04009338A MXPA04009338A MXPA04009338A MXPA04009338A MX PA04009338 A MXPA04009338 A MX PA04009338A MX PA04009338 A MXPA04009338 A MX PA04009338A MX PA04009338 A MXPA04009338 A MX PA04009338A MX PA04009338 A MXPA04009338 A MX PA04009338A
Authority
MX
Mexico
Prior art keywords
acid
hfa
contain
tiotropium
suspensions
Prior art date
Application number
MXPA04009338A
Other languages
English (en)
Spanish (es)
Inventor
Schmelzer Christel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04009338A publication Critical patent/MXPA04009338A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
MXPA04009338A 2002-03-28 2003-03-20 Formulaciones de un anhidrato en suspension con hfa. MXPA04009338A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (fr) 2002-03-28 2003-03-20 Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa

Publications (1)

Publication Number Publication Date
MXPA04009338A true MXPA04009338A (es) 2005-01-25

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04009338A MXPA04009338A (es) 2002-03-28 2003-03-20 Formulaciones de un anhidrato en suspension con hfa.

Country Status (21)

Country Link
EP (1) EP1492498A2 (fr)
JP (1) JP5147158B2 (fr)
KR (1) KR101005717B1 (fr)
CN (1) CN1642525A (fr)
AU (1) AU2003221509B2 (fr)
BR (1) BR0308709A (fr)
CA (1) CA2479638C (fr)
DE (1) DE10214264A1 (fr)
EA (1) EA008610B1 (fr)
EC (1) ECSP045322A (fr)
HR (1) HRP20040890A2 (fr)
IL (1) IL163696A0 (fr)
ME (1) ME00246B (fr)
MX (1) MXPA04009338A (fr)
NO (1) NO20044004L (fr)
NZ (1) NZ536030A (fr)
PL (1) PL371295A1 (fr)
RS (1) RS52481B (fr)
UA (1) UA79776C2 (fr)
WO (1) WO2003082244A2 (fr)
ZA (1) ZA200405637B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1881980E (pt) * 2005-05-02 2012-12-06 Boehringer Ingelheim Int Novas formas cristalinas de brometo de tiotrópio
CA2606552A1 (fr) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Formes cristallines de bromure de tiotropium
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
TWI792140B (zh) * 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
EP3515439B1 (fr) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant du bromure de tiotropium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
AU2002214030A1 (en) * 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses

Also Published As

Publication number Publication date
NO20044004L (no) 2004-10-05
HRP20040890A2 (en) 2005-06-30
NZ536030A (en) 2006-07-28
CA2479638C (fr) 2011-01-04
ME00246B (fr) 2011-05-10
KR20040098022A (ko) 2004-11-18
EP1492498A2 (fr) 2005-01-05
PL371295A1 (en) 2005-06-13
JP5147158B2 (ja) 2013-02-20
ECSP045322A (es) 2005-01-28
CN1642525A (zh) 2005-07-20
CA2479638A1 (fr) 2003-10-09
EA008610B1 (ru) 2007-06-29
RS52481B (en) 2013-02-28
KR101005717B1 (ko) 2011-01-05
MEP47308A (en) 2011-02-10
WO2003082244A3 (fr) 2004-02-05
YU86004A (sh) 2006-08-17
UA79776C2 (en) 2007-07-25
AU2003221509B2 (en) 2008-01-24
EA200401159A1 (ru) 2005-04-28
DE10214264A1 (de) 2003-10-16
WO2003082244A2 (fr) 2003-10-09
JP2005527550A (ja) 2005-09-15
BR0308709A (pt) 2005-01-04
ZA200405637B (en) 2005-07-27
AU2003221509A1 (en) 2003-10-13
IL163696A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
MXPA03003221A (es) Monohidrato cristalino, procedmiento para su preparacion y su uso para la preparacion de un medicamento.
US7736627B2 (en) HFA suspension formulations containing an anticholinergic
KR20010101128A (ko) 마크로리드의 안정화 방법
MXPA06004940A (es) Nuevo anhidrato cristalino con accion anticolinerg
MXPA04009338A (es) Formulaciones de un anhidrato en suspension con hfa.
EP0365119B1 (fr) Composition pharmaceutique
MXPA04009337A (es) Formulaciones en suspension con hfa que contienen un anticolinergico.
US7244415B2 (en) HFA suspension formulations of an anhydrate

Legal Events

Date Code Title Description
FG Grant or registration